Notice of 18th Annual General Meeting

Ordinary Business Agenda

1. To receive, consider and adopt the audited financial statements (including consolidated financial statements) of the Company for the financial year ended 31st March, 2026 together with Reports of the Board of Directors and Auditors.

2. To appoint a director in place of Dr. Anil Ghogare (DIN 00432659), who retires by rotation and being eligible, offers himself for re-appointment.

Director Information for Re-appointment

  • Name: Dr. Anil Ghogare
  • DIN: 00432659
  • Designation: Non-Executive Non-Independent Director
  • Age: 65 years (17th June 1960)
  • Date of Appointment: 10th November 2023
  • Educational Qualifications: MBA Finance (M.S. University, Baroda), Ph.D. in Pharmaceutical Chemistry (Mumbai University), M.Tech Chemical & Instrumentation (IIT Delhi), M.Sc. Organic Chemistry (Pune University)
  • Experience: 37 years in Fermentation Technology, GMP/Regulatory consultant for plant design, technology transfers
  • Remuneration: Nil
  • Shareholding: Nil
  • Board Meetings Attended: 7 out of 7 during the financial year
  • Other Directorships: Nil

Voting Arrangements

  • Remote e-voting period: Saturday, 19th September 2026 at 9:00 a.m. to Monday, 21st September 2026 at 5:00 p.m.
  • Record date (cut-off date): Tuesday, 15th September 2026
  • Voting rights proportional to shareholding as on record date
  • NSDL appointed as authorized agency for e-voting facility
  • Scrutinizer: CS Mr. Vishal Manseta (Membership no. 25183)

Virtual Meeting Details

  • AGM conducted through VC/OAVM in compliance with MCA General Circulars
  • Facility available to first 1000 members on first-come-first-serve basis
  • Large shareholders (2%+), promoters, institutional investors, directors, KMPs exempt from first-come restriction
  • Members can join 15 minutes before and after scheduled commencement time
  • Questions can be raised through chat box during meeting
  • Members must register as speakers at least 7 days before AGM by email to compliance@sudarshanpharma.com

Document Distribution

  • Annual Report for FY 2025-26 being sent electronically to all members with registered email addresses
  • Notice uploaded on company website (www.sudarshanpharma.com), BSE website (www.bseindia.com), and NSDL website (www.evoting.nsdl.com)